@snpoehlm.bsky.social
@snpoehlm.bsky.socialNew sequences from Germany 🇩🇪, all collected in September. No PJ.2.1 - so far. #PJ21
@snpoehlm.bsky.social4 out of 50 new sequences from Syracuse, NY, USA, are PJ.2.1 #PJ21
Patients are in age groups 0-9 and 65+
@snpoehlm.bsky.socialOne new PJ.2.1 from Spain 🇪🇸
The sample was collected from a one-month-old, non-hospitalized male in Vitoria-Gasteiz, northern Spain.
Among 90 newly submitted sequences - many collected in September - only one was PJ.2.1. Its spread may therefore be less robust than initially persumed. #PJ21
@snpoehlm.bsky.socialNew PJ.2.1 sequences from Spain 🇪🇸
Roughly 9% of sequences from Spain collected in September are PJ.2.1
Roughly 15% of sequences from Spain submitted since September 15 are PJ.2.1 #PJ21
@snpoehlm.bsky.socialNew PJ.2.1 sequences from Spain 🇪🇸
Roughly 7% of sequences from Spain collected in September are PJ.2.1
Roughly 15% of sequences from Spain submitted since September 15 are PJ.2.1 #PJ21
@snpoehlm.bsky.social🧪6 new PJ.2.1 sequences from Spain 🇪🇸
Most patients were aged 55+, as expected. Two were hospitalized.
📍 4 — San Sebastián
📍 1 — Madrid
📍 1 — Bilbao
PJ.2.1 is likely circulating more broadly, but only 6 of 141 samples were PJ.2.1, suggesting it is not yet dominant.
@snpoehlm.bsky.socialThese developments underscore the importance of maintaining at least a baseline level of genomic surveillance. #PJ21
@snpoehlm.bsky.social4/4 Most PJ.2.1 detections in Spain so far have been reported in older adults, in agreement with data from Canada and the US. Let's see whether this pattern continues as more cases are identified. #PJ21
@snpoehlm.bsky.socialIt is noteworthy that the initial PJ.2.1 sequences were almost exclusively obtained from patients in the above 65 years age group.
Some of the recent sequences were collected from younger individuals.
Need to monitor this development. #PJ21
@snpoehlm.bsky.socialTwo new PJ.2.1 sequences today, one from Maryland, USA 🇺🇸, and one from Catalunya, Spain 🇪🇸. #PJ21